Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ<sup>®</sup>Tablets), the first orally available drug for cancer cachexia with ghrelin-like action in Japan-Reference-Cited by-同舟云学术

Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ^®Tablets), the first orally available drug for cancer cachexia with ghrelin-like action in Japan

Published:2021 Issue:6 Volume:156 Page:370-381
ISSN:0015-5691
Container-title:Folia Pharmacologica Japonica
language:en
Short-container-title:Folia Pharmacol. Jpn.

Author:

Nakanishi Yasutomo¹,Higuchi Junya²,Honda Naoki³,Komura Naoyuki⁴

Affiliation:

1. Discovery & Research, Research Center of Specialty, Ono Pharmaceutical Co., Ltd.

2. Discovery & Research, Research promotion, Ono Pharmaceutical Co., Ltd.

3. ONO Pharma UK Ltd.

4. Clinical Development, Clinical Development Planning II, Ono Pharmaceutical Co., Ltd.

Publisher

Japanese Pharmacological Society

Subject

Pharmacology

Link

https://www.jstage.jst.go.jp/article/fpj/156/6/156_21046/_pdf

Reference46 articles.

1. 1) EPCRC. Clinical practice guidelines on cancer cachexia in advanced cancer patients with a focus on refractory cachexia: European Clinical Guidelines 2011.

2. 2) 日本緩和医療学会緩和医療ガイドライン委員会. 終末期がん患者の輸液療法に関するガイドライン. 2013年版. p. 46-52.

3. 3) 乾明夫. 癌と化学療法. 2005;32:743-749.

4. 4) Takayama K, et al. Support Care Cancer. 2016;24:3473-3480.

5. 5) Takayama K, et al. J Thorac Oncol. 2011;6:S1202.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The synergistic potential of GLP-1R agonist dulaglutide and ghrelin receptor analogue anamorelin in ameliorating muscle atrophy;Medical Hypotheses;2024-08

2. Ghrelin in Focus: Dissecting Its Critical Roles in Gastrointestinal Pathologies and Therapies;Current Issues in Molecular Biology;2024-01-22

3. Emerging Relevance of Ghrelin in Programmed Cell Death and Its Application in Diseases;International Journal of Molecular Sciences;2023-12-08

4. Anamorelin in Japanese patients with cancer cachexia: an update;Current Opinion in Supportive & Palliative Care;2023-06-30

5. First case report of anamorelin-induced fatal arrhythmia complicated by sinus arrest and refractory ventricular tachycardia;HeartRhythm Case Reports;2023-03